Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Recently Diagnosed Impaired Left Ventricular Function: a Multicenter, Randomized Controlled Trial

NCT02509754 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT02509754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02509754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Recently Diagnosed Impaired Left Ventricular Function: a Multicenter, Randomized Controlled Trial
Lead sponsor
University of Turin, Italy
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2016
Completion date
December 31, 2017
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure due to left ventricular systolic dysfunction, persistent atrial fibrillation